$284.05 Bottle
India
140mg
Bottle
Ibrutinib 140mg, marketed as Imbruvica, is indicated for the treatment of: Mantle cell lymphoma (MCL), Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL), Waldenström's macroglobulinemia (WM), Marginal zone lymphoma (MZL), Chronic graft-versus-host disease (cGVHD). Category: Anticancer, specifically a Bruton's tyrosine kinase (BTK) inhibitor.
IN1
Ibrutinib
There are no reviews yet.
Your email address will not be published. Required fields are marked *
Your review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
This will update your shipping location for calculating shipping options.
Reviews
There are no reviews yet.